Qi (Kristine) Wan
Principal Scientist Abbvie
Dr. Qi (Kristine) Wan, M.D., Ph.D., is a dynamic immunologist with over a decade of experience in the biopharmaceutical industry, specializing in inflammatory and autoimmune disease therapeutics. Currently a Principal Scientist at AbbVie Cambridge Research Center, she excels in drug discovery and development, particularly in advancing preclinical pipelines and target identification for immune tolerance restoration. Throughout her career, Dr. Wan has led high-impact projects and external collaborations, earning accolades such as the 2024 Ironman Award. A prolific author, she has contributed significantly to peer-reviewed publications and is a renowned expert in innovative immunology research platforms.
Seminars
Monday 27th October 2025
Targeted Delivery of Biological PROTACs: A New Approach for Degrading Challenging Protein Targets
3:30 pm
- Biological PROTACs act as novel intracellular mechanisms to degrade undruggable proteins
- Antibody-based nanoparticles effectively address challenges in intracellular protein delivery
- Achieving efficient, targeted degradation offers new treatments for various diseases, including autoimmune disorders
